Effects of Cytochalasin B on Actin and Myosin Association With
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Unique PKD Like Protein Kinase in Entamoeba Histolytica Regulates Vital Actin Mediated 2 Processes 3 4 Mithu Baidya, Santoshi Nayak, Amit K
bioRxiv preprint doi: https://doi.org/10.1101/677500; this version posted June 20, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Unique PKD like protein kinase in Entamoeba histolytica regulates vital actin mediated 2 processes 3 4 Mithu Baidya, Santoshi Nayak, Amit K. Das, Sudip Kumar Ghosh# 5 6 Department of Biotechnology, Indian Institute of Technology Kharagpur, Kharagpur, West Bengal 7 721 302, India. 8 #Address Correspondence to Sudip K. Ghosh, [email protected] 9 Telephone no: (+91) 3222 283768 Fax: (+91) 3222 278707 10 11 12 Abstract 13 Entamoeba histolytica causes widespread amoebiasis in humans. Multiple lines of emerging 14 evidence have identified a repertoire of proteins involved in the process of erythrophagocytosis. 15 However, the early initiation of the erythrophagosome at the site of erythrocyte's attachment is 16 not well understood. Here in our study we have identified and characterized a small Protein kinase 17 D like protein (EhPKDL) in Eh, which nucleates actin polymerization and thus mediates many vital 18 processes in Eh including erythrophagocytosis. Following multiple biochemical and biophysical 19 approaches, we have characterized EhPKDL and have shown that EhPKDL can indeed interact and 20 prime the nucleation of monomeric actin for polymerization. Furthermore, we went on to 21 demonstrate the vitality of the EhPKDL in major actin-mediated processes like capping, motility, 22 and erythrophagocytosis following knockdown of EhPKDL in the cellular context. Our study thus 23 provides novel insights into the early actin nucleation in Eh and thus bridges the gap with our 24 previous understanding of the assembly of erythrophagosomes. -
The Sensitivity of Developing Cardiac Myofibrils to Cytochalasin-B (Electron Microscopy/Polarized Llght/Z-Bands/Heartbeat) FRANCIS J
Proc. Nat. Acad. Sci. USA Vol. 69, No. 2, pp. 308-312, February 1972 The Sensitivity of Developing Cardiac Myofibrils to Cytochalasin-B (electron microscopy/polarized llght/Z-bands/heartbeat) FRANCIS J. MANASEt,* BETH BURNSIDEt't, AND JOHN STROMAN* * Departments of Anatomy and Pediatrics, Harvard Medical School, Boston, Massachusetts 02115; Department of Cardiology and Pathology, The Children's Hospital Medical Center, Boston, Mass. 02115; and t Department of Anatomy, Harvard Medical School, Boston, Mass. 02115 Communicated by Keith R. Porter, November 12, 1971 ABSTRACT Developing cardiac muscle cells of 11- to (about 30-40 hr of incubation) were selected. The splanchno- 13-somite chick embryos are sensitive to cytochalasin-B. the In cultured chick embryos, ranging in development from pleure of the developing yolk sac was removed, exposing 11 to 13 somites, hearts stop beating in the presence of this heart. If care is taken to prevent damage to the anterior in- agent. Both polarized light and electron microscopic testinal portal, this surgical procedure does not interfere with examination show that cytochalasin-B disrupts existing normal development during the time periods used in this myofibrils and inhibits the formation of new ones. Dis- study. In experimental series, the culture medium was re- crete Z-bands are not present in treated heart cells and thick, presumably myosin, filaments are found in dis- placed with either 0.1 mM (50 ug/ml) or 20 ,gM (10 jsg/ml) array. These effects are reversible; after cytochalasin-B is cytochalasin-B in Tyrodes solution plus 1% dimethyl sulf- removed from the medium, heartbeat recovers and myo- oxide (Me2SO) for specified incubation times. -
Modulation of Lymphocyte Receptor Mobility by Locally Bound
Proc. Nat. Acad. Sci. USA Vol. 72, No. 4, pp. 1579-1583, April 1975 Modulation of Lymphocyte Receptor Mobility by Locally Bound Concanavalin A (cell membrane/cap formation/lectins/insolubilized concanavalin A) ICHIRO YAHARA AND GERALD M. EDELMAN The Rockefeller University, New York, N.Y. 10021 Contributed by Gerald M. Edelman, February 7, 1975 ABSTRACT Binding of concanavalin A (Con A) to the capping phenomenon raised the possibility that our earlier lymphocyte surface at room temperature leads to restric- observations on restriction of receptor mobility by Con A tion of the mobility of a variety of cell surface receptors in- immobilization of various cluding those for immunoglobulin (Ig), 0, H-2, j02-micro- might be explained by simple globulin, Fc receptors, as well as receptors for other receptors after their cross-linkage by multivalent Con A lectins. Addition of colchicine to the cell suspensions molecules to Con A receptors that are in turn anchored to reverses this effect and allows Con A receptors as well the hypothesized cytoplasmic assembly. as other receptors to form patches and caps. Cap- this we have prepared Con A ping of Con A receptors results in "co-capping" of Ig, In order to test possibility, H-2, 6, Fc receptors, and 62-microglobulin in the ab- bound to platelets and latex beads and have shown that local sence of ligands specific for these receptors. Receptors attachment of these particles to a small fraction of Con A binding Limulus hemagglutinin and wax bean agglutinin, receptor sites on the cell surface inhibits the mobility of Ig as well as those interacting with carbohydrate-specific and other receptors. -
Mir-34/449 Control Apical Actin Network Formation During Multiciliogenesis Through Small Gtpase Pathways
ARTICLE Received 7 Jul 2015 | Accepted 17 Aug 2015 | Published 18 Sep 2015 DOI: 10.1038/ncomms9386 OPEN miR-34/449 control apical actin network formation during multiciliogenesis through small GTPase pathways Benoıˆt Chevalier1,2,*, Anna Adamiok3,*, Olivier Mercey1,2,*, Diego R. Revinski3, Laure-Emmanuelle Zaragosi1,2, Andrea Pasini3, Laurent Kodjabachian3, Pascal Barbry1,2 & Brice Marcet1,2 Vertebrate multiciliated cells (MCCs) contribute to fluid propulsion in several biological processes. We previously showed that microRNAs of the miR-34/449 family trigger MCC differentiation by repressing cell cycle genes and the Notch pathway. Here, using human and Xenopus MCCs, we show that beyond this initial step, miR-34/449 later promote the assembly of an apical actin network, required for proper basal bodies anchoring. Identification of miR-34/449 targets related to small GTPase pathways led us to characterize R-Ras as a key regulator of this process. Protection of RRAS messenger RNA against miR-34/449 binding impairs actin cap formation and multiciliogenesis, despite a still active RhoA. We propose that miR-34/449 also promote relocalization of the actin binding protein Filamin-A, a known RRAS interactor, near basal bodies in MCCs. Our study illustrates the intricate role played by miR-34/449 in coordinating several steps of a complex differentiation programme by regulating distinct signalling pathways. 1 CNRS, Institut de Pharmacologie Mole´culaire et Cellulaire (IPMC), UMR-7275, 660 route des Lucioles, 06560 Sophia-Antipolis, France. 2 University of Nice-Sophia-Antipolis (UNS), Institut de Pharmacologie Mole´culaire et Cellulaire, 660 route des Lucioles, Valbonne, 06560 Sophia-Antipolis, France. -
SAFETY DATA SHEET Revision Date 04/30/2021 Print Date 09/25/2021
Version 6.3 SAFETY DATA SHEET Revision Date 04/30/2021 Print Date 09/25/2021 SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1 Product identifiers Product name : Cytochalasin B, from Drechslera dematioidea Product Number : C6762 Brand : Sigma CAS-No. : 14930-96-2 1.2 Relevant identified uses of the substance or mixture and uses advised against Identified uses : Laboratory chemicals, Synthesis of substances 1.3 Details of the supplier of the safety data sheet Company : Sigma-Aldrich Inc. 3050 SPRUCE ST ST. LOUIS MO 63103 UNITED STATES Telephone : +1 314 771-5765 Fax : +1 800 325-5052 1.4 Emergency telephone Emergency Phone # : 800-424-9300 CHEMTREC (USA) +1-703- 527-3887 CHEMTREC (International) 24 Hours/day; 7 Days/week SECTION 2: Hazards identification 2.1 Classification of the substance or mixture GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) Acute toxicity, Oral (Category 2), H300 Acute toxicity, Inhalation (Category 1), H330 Acute toxicity, Dermal (Category 2), H310 Reproductive toxicity (Category 2), H361 For the full text of the H-Statements mentioned in this Section, see Section 16. 2.2 GHS Label elements, including precautionary statements Pictogram Signal word Danger Sigma - C6762 Page 1 of 10 The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the US and Canada Hazard statement(s) H300 + H310 + H330 Fatal if swallowed, in contact with skin or if inhaled. H361 Suspected of damaging fertility or the unborn child. Precautionary statement(s) P201 Obtain special instructions before use. P202 Do not handle until all safety precautions have been read and understood. -
The Cellular Response to Cytochalasin B: a Critical Overview
Cytologia 39: 709-727 , 1974 The Cellular Response to Cytochalasin B: A Critical Overview Michelle Copeland Children'sCancer Research Foundation , 35 BinneyStreet, Boston, Massachusetts02115 , U. S. A. ReceivedApril 3, 1973 The cytochalasins comprise a novel class of fungal metabolites which have attracted a great deal of recent interest as a result of the numerous apparently di versecytological effects which are elicited by their presence, both in vivo and in vitro. Six cytochalasins have been isolated, to date, from the cultures of Helminthospor ium dematioidem, Metarrhizium anisopliae, and Rosellina necatrix, although some what similar biological activity has been associated with the fermentation products of several additional fungi (Aldridge et al. 1967). The six currently isolable cyto chalasins are designated A, B, C, D, E, and F. In terms of their biological activity, i nsofar as this is known at present, these six cytochalasins appear qualitatively simi lar to one another, although the potencies of the isomeric cytochalasins C and D Aldridge et al., 1967 Chem. Comm. 1: 26 Fig. 1. The chemical structure of cytochalasin B. exceedthose of cytochalasins A and B by a factor of approximately ten (Carter 1967). Themost readily isolated of these is the B variant , which has been shown to be iden tical with the antibiotic "phomin" (Aldrige and Turner 1968) (Fig. 1). The addi tional features of appropriate potency , essential nontoxicity at low concentrations and reversibility of action have made cytochalasin B the subject of most laboratory studies of the biological phenomena produced by the cytochalasins. Preliminary investigators employed the term"cytochalasin" (from the Greek cytos: cell;+chalasis: relaxation) to denote the cytological changes induced by these metabolic end-products . -
Entamoeba Histolytica
INFECTION AND IMMUNITY, Nov. 1995, p. 4358–4367 Vol. 63, No. 11 0019-9567/95/$04.0010 Copyright q 1995, American Society for Microbiology Myosin II Is Involved in Capping and Uroid Formation in the Human Pathogen Entamoeba histolytica 1 2 1 1 PHILIPPE ARHETS, PIERRE GOUNON, PHILIPPE SANSONETTI, AND NANCY GUILLE´N * Unite´ de Pathoge´nie Microbienne Mole´culaire, Institut National de la Sante´ et de la Recherche Me´dicale U389,1 and Station Centrale de Microscopie Electronique,2 Institut Pasteur, 75724 Paris Ce´dex 15, France Received 7 April 1995/Returned for modification 30 May 1995/Accepted 20 July 1995 The redistribution and capping of surface receptors on the human pathogen Entamoeba histolytica was observed in the presence of concanavalin A (ConA). Capping was correlated with plasma membrane folding towards the rear of the amoeba and with uroid formation. The uroid is thought to play a role in the escape of amoebae from the host immune response. To localize myosin II during capping, amoebae were incubated in the presence of ConA and then analyzed by microscopy. Myosin II was three times more concentrated within the uroid compared with the rest of the cell, suggesting that the release of caps may depend upon mechanical contraction driven by myosin II activity. The use of drugs that disrupt cytoskeletal structure or that inhibit myosin heavy chain phosphorylation demonstrated that inhibition of capping prevents uroid formation. Biochemical analysis allowed the identification of two ConA receptors which have been previously described as major pathogenic antigens of this parasite: the 96-kDa antigen, which carries alcohol dehydrogenase 2 activity and binds extracellular matrix proteins, and the Gal-GalNAc-inhibitable surface lectin, which is involved in amoeba-cell interactions and in the degradation of complement particles attached to the parasite. -
Identification of New GLUT2-Selective Inhibitors Through in Silico Ligand
www.nature.com/scientificreports OPEN Identifcation of new GLUT2‑selective inhibitors through in silico ligand screening and validation in eukaryotic expression systems Sina Schmidl1,7, Oleg Ursu2,6,7, Cristina V. Iancu3, Mislav Oreb1, Tudor I. Oprea2,4* & Jun‑yong Choe3,5* Glucose is an essential energy source for cells. In humans, its passive difusion through the cell membrane is facilitated by members of the glucose transporter family (GLUT, SLC2 gene family). GLUT2 transports both glucose and fructose with low afnity and plays a critical role in glucose sensing mechanisms. Alterations in the function or expression of GLUT2 are involved in the Fanconi– Bickel syndrome, diabetes, and cancer. Distinguishing GLUT2 transport in tissues where other GLUTs coexist is challenging due to the low afnity of GLUT2 for glucose and fructose and the scarcity of GLUT‑specifc modulators. By combining in silico ligand screening of an inward‑facing conformation model of GLUT2 and glucose uptake assays in a hexose transporter‑defcient yeast strain, in which the GLUT1‑5 can be expressed individually, we identifed eleven new GLUT2 inhibitors (IC50 ranging from 0.61 to 19.3 µM). Among them, nine were GLUT2‑selective, one inhibited GLUT1‑4 (pan‑Class I GLUT inhibitor), and another inhibited GLUT5 only. All these inhibitors dock to the substrate cavity periphery, close to the large cytosolic loop connecting the two transporter halves, outside the substrate‑binding site. The GLUT2 inhibitors described here have various applications; GLUT2‑specifc inhibitors can serve as tools to examine the pathophysiological role of GLUT2 relative to other GLUTs, the pan‑Class I GLUT inhibitor can block glucose entry in cancer cells, and the GLUT2/GLUT5 inhibitor can reduce the intestinal absorption of fructose to combat the harmful efects of a high‑fructose diet. -
The Mechanism of Concanavalin a Cap Formation in Leukocytes
J. Cell Set. a6, 57-75 (1977) 57 Printed in Great Britain THE MECHANISM OF CONCANAVALIN A CAP FORMATION IN LEUKOCYTES D. F. ALBERTINI*, R. D. BERLIN* AND J. M. OLIVERf Departments of Physiology* and Pathologyf, University of Connecticut Health Center, Farmington, Connecticut 06032, U.S.A. SUMMARY The process of Concanavalin A (Con A) cap formation on human blood polymorphonuclear leukocytes, monocytes and lymphocytes and rabbit alveolar macrophages has been studied by correlative use of light, fluorescence and electron microscopy. The most important precondition for Con A capping on these cells is the disassembly of cytoplasmic microtubules by colchicine or the glutathione-oxidizing agent, 'diamide'. Incubation of microtubule-depleted leukocytes with fluorescein-conjugated Con A (F-Con A) leads to the aggregation of lectin into a cap which usually occupies a protuberance at one pole of the cell. F-Con A can also be concentrated at a constriction in the cell body. The protuberance is shown to consist of highly plicated mem- brane subtended by a network of densely packed microfilaments. Additional microfUaments originate from this network and course into individual plications of the protuberance. How- ever, the formation of the protuberance with its organized structure follows the disassembly of microtubules alone and does not require Con A. Thus when cells are treated with colchicine or diamide, then fixed and labelled with F-Con A the typical changes in cell shape that are associated with capping are observed but lectin is distributed homogeneously over the cell surface. Similarly if cells are first capped with low concentrations of unlabelled lectin, then fixed and incubated with F-Con A, fluorescence is again uniformly distributed over the whole membrane. -
In Vitro Micronucleus Test
DRAFT GUIDELINE (2nd version) 21 December 2006 OECD GUIDELINE FOR THE TESTING OF CHEMICALS DRAFT PROPOSAL FOR A NEW GUIDELINE 487: In Vitro Micronucleus Test INTRODUCTION 1. The in vitro micronucleus assay is a genotoxicity test system used for the detection of micronuclei in the cytoplasm of interphase cells. These micronuclei may originate from acentric fragments (chromosome fragments lacking a centromere) or whole chromosomes that are unable to migrate with the rest of the chromosomes during the anaphase of cell division. The assay detects the activity of both clastogenic and aneugenic chemicals (1, 2) in cells that have undergone cell division after exposure to the test substance. Development of the cytokinesis-block methodology, by addition of the actin polymerisation inhibitor cytochalasin B during the targeted mitosis, allows the identification and selective analysis of micronucleus frequency in cells that have completed one cell division as such cells are binucleate (3, 4). However, the Test Guideline also allows the use of protocols without cytokinesis block, provided there is evidence that the majority of cells analysed are likely to have undergone cell division. 2. The immunochemical labelling (FISH) of kinetochores, or hybridisation with general or chromosome specific centromeric/telomeric probes can provide useful information on the mechanism of micronucleus formation (5). Use of cytokinesis block facilitates the acquisition of the additional mechanistic information (e.g., chromosome non-disjunction) that can be obtained by FISH-techniques (6- 15). 3. The micronucleus assay has a number of advantages over metaphase analysis performed to measure chromosome aberrations in the OECD Guidelines 473 and 475 (16, 17). -
Transmembrane Interactions and Themechanism of Capping
Proc. Natl. Acad. Sci. USA Vol. 74, No. 11, pp. 5031-5035, November 1977 Cell Biology Transmembrane interactions and the mechanism of capping of surface receptors by their specific ligands (non-muscle-cell myosin and actin/T lymphocytes/HeLa cells/sliding filament mechanism) LILLY Y. W. BOURGUIGNON* AND S. J. SINGERt Department of Biology, University of California, San Diego, La Jolla, California 92093 Contributed by S. J. Singer, August 19, 1977 ABSTRACT The mechanism of capping of cell surface re- MATERIALS AND METHODS ceptors has been examined by a double fluorescence staining procedure that permitted simultaneous observations of the Mouse splenic T lymphocytes were obtained from C57BL/6J distribution of a surface-bound ligand together with intracel- mice and were prepared by passing the spleen cells over a nylon lular actin or myosi At an early stage in the capping of the T-25 wool column as described (5). HeLa cells grown in Eagle's antigen or the H2 histocompati i ity antigens on mouse splenic minimal essential suspension medium supplemented with 10% T lymphocytes, or of concanavalin A receptors on HeLa cells, fetal calf serum at 370 were obtained from M. Goulian. Mouse when the specific receptors in question were collected into patches that were distributed over the entire cell surface, the antisera to the H2b haplotype were the gift of Robert Hyman, intracellular membrane-associated actin or myosin was also and rabbit antisera to the antigen T-25 (otherwise known as accumulated into patches that were located directly under the Thy-i or 0) were generously provided by Ian Trowbridge. -
With Deuterium Oxide, Colchicine, and Cytochalasin B
Histamine Release from Human Leukocytes: Studies with Deuterium Oxide, Colchicine, and Cytochalasin B ELIZABETH GLLESPIE and LAWRENCE M. LICHTENSTEIN From the Division of Clinical Immunology, The Johns Hopkins University School of Medicine at The Good Samaritan Hospital, Baltimore, Maryland 21239 A B S T R A C T Agents known to interact with either INTRODUCTION microtubules or microfilaments influenced the antigen-in- Antigen-mediated release of histamine from the duced release of histamine from the leukocytes of al- leuko- lergic individuals. Deuterium oxide (D20) cytes of allergic individuals is a good in vitro model for which sta- allergic reactions. The extent of bilizes microtubules and thereby favors their formation release correlates well enhanced histamine release with clinical symptoms (1) and drugs, e.g., isoproterenol markedly. Concentrations and theophylline, which alleviate the as low as 5% increased antigen-induced release somne- in vivo symptoms also inhibit the in vitro release what while concentrations as high as 75% had no effect process (2). At the same time the mechanism by which histamine is released from on release in the absence of antigen. Enhancement oc- leukocytes curred over a wide range of antigen is fundamentally similar to the release process concentrations and in other tissues, with cell-bound was also seen when release was initiated by antibody (IgE) acting antibody to as a IgE or IgG. When the release process was divided into receptor and antigen replacing a hormone or other two stages a D20 activity could be demonstrated only releasing agent. in the second stage. However, when D20 was present in Colchicine, a drug known to disrupt microtubules, has the first stage together with agents which raise cyclic been shown to inhibit the release of a variety of com- AMP levels and thereby inhibit release it partially re- pounds (3-6) including histamine from leukocytes (7).